News and Comments

COULD AGENUS VACCINE FOR GLIOBLASTOMA BE ASSIGNED BREAKTHROUGH DESIGNATION?

  Tuesday, September 17, 2013

AGENUS (AGEN) has extraordinary news. A recent analysis from a Phase 2 trial in patients with newly diagnosed glioblastoma multiforme (GBM) treated with Prophage Series G-100 (HSPPC-96) in combination with the current standard of care (radiation and temozolomide) showed an almost 18 month median progression free survival (PFS), which represents a 160% increase versus current standard of care alone. The results confirm continuation of the positive trends from the Phase 2 HSPPC-96 newly diagnosed GBM trial first reported at the 81st American Association of Neurological Surgeons (AANS) Annual Scientific Meeting in May 2013. More...

AGENUS OFFERS AN INVESTMENT OPPORTUNITY.

  Saturday, September 07, 2013

 More...


Recent Postings


Archive


Tags

Sanofi-Aventis (SAN) Ziofpharm (ZIOP) Regeneron (REGN) Vertex (VRTX) Biocryst (BCRX) Velcade (bortezomib) Sanofi (SNY) Tysabri ZALTRAP™ Adaptimmune (ADAP) Micromet (MITI) VANDA (VNDA) Prosensa (RNA) CEMPRA (CEMP) Biogen Idec (BIIB) KERYX (KERX) Telaprevir Abbott Laboratories (ABT) ACADIA (ACAD) AERIE PHARMACEUTICALS AGOS (ARGS) Multiple Myeloma Sarepta (SRPT) Aimmune Therapeutics (AIMT) AstraZeneca (AZN) ImmunoGen (IMGN) IDERA (IDRA) Cytokinetics (CYTK) Mirati Therapeutics (MRTX) Inovio (INO) Jazz Pharmaceuticals (JAZZ) C4 Therapeutics ARCA (ABIO) Zerenex Valeant Pharmaceuticals International (VRX) Bellicum (BLCM) Revlimid (lenolidamide) Array Pharmaceuticals (ARRY) Intermune (ITMN) Rapamune CompuGen (CGEN) Alder Biopharmaceuticals (ALDR) Amgen (AMGN) ARGOS (ARGS) Dynavax (DVAX) Roche (RHHBY) Ocular Therapeutix (OCUL) Dendreon (DNDN) INNOVIVA (INVA) SERES THERAPEUTICS (MCRB) GlaxoSmithKline (GSK) Endometrial Cancer Theravance Bio Pharma (TBPH) Illumina (ILMN) Elan (ELN) ABBVIE (ABBV) Gilead (GILD) Agenus (AGEN) Agenus (AGEN Benlysta (belimumab) Anadys (ANDS) HALOZYME (HALO) MODERNA OSI (OSIP) Roche (ROCHE) Vitae Pharmaceuticals (VTAE) REGULUS (RGLS) Sangamo (SGMO) Seattle Genetics (SGEN) Ridaforolimus Spike Therapeutics (ONCE) NEKTAR (NKTR)) Ariad (ARIA) Intrexon (XON) GUARDIAN HEALTH Human Longevity (HLI) NOVOCURE (NVCR) Sequenom (SQNM) JUNO (JUNO) CRISPR Therapeutics (CRSP) Genentech galapagos (GLPG) RenenxBio (RGNX) Onyx (ONXX) Theravance (THRX) Alnylam (ALNY) Prolor Biotech (PBTH) Advaxis (ADXS) SYNTA (SNTA) Human Genome Sciences (HGSI) Idenix (IDIX) Ionis (IONS) KITE (KITE) ADVENTRIX (ANX) Merck (MRK) Incyte (INCY) Global Cell Therapeutics (GBT) Exelixis (EXEL) NANTKWEST (NK) Pluristem (PSTI) Auspex (ASPX) Editas (EDIT) ISIS (ISIS) Bristol-Myers Squibb (BMY) PTC Therapeutics (PTCT) BIOMARIN (BMRN) Anacor (ANAC) Galena (GALE) Sanofi (SNA) Trastuzumab-DM1 Intercept (ICPT) SUNESIS PHARMACEUTICALS (SNSS) TOKAI (TKAOI) Xoma (XOMA) Herceptin